Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Pope

Showing results (51-60 of 167) with videos related to

Pageof 17
Sort By:
The Journal of Rheumatology|April 3, 2012
Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosisMarie Hudson, Michael Mahler, Janet Pope, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 2, 2011
A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritisMaria de Los Angeles Pineda, Sarah Frances Thompson, Kelly Summers, et al.
Respiratory Medicine|October 18, 2016
RISE-SSc: Riociguat in diffuse cutaneous systemic sclerosisOliver Distler, Janet Pope, Chris Denton, et al.
Arthritis and Rheumatism|July 20, 2011
Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single centerJanet Pope, Donna McBain, Lisa Petrlich, et al.
Arthritis Care & Research|September 1, 2010
Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspectiveJessica Widdifield, Sasha Bernatsky, J Michael Paterson, et al.
Rheumatology (Oxford, England)|August 15, 2019
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 yearsJanet Pope, Louis Bessette, Niall Jones, et al.
Arthritis Care & Research|July 27, 2012
Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritisJessica Widdifield, Sasha Bernatsky, J Michael Paterson, et al.
Arthritis and Rheumatism|January 1, 2009
The cost of systemic sclerosisSasha Bernatsky, Marie Hudson, Pantelis Panopalis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 4, 2024
Characterization of Incident Interstitial Lung Disease in Late Systemic SclerosisSabrina Hoa, Claudie Berger, Nouha Lahmek, et al.
Open Access Rheumatology : Research and Reviews|June 17, 2024
Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment RetentionJanet Pope, Axel Finckh, Lucia Silva-Fernández, et al.
Pageof 17

Showing results (51-60 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Rheumatology|April 3, 2012
Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosisMarie Hudson, Michael Mahler, Janet Pope, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 2, 2011
A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritisMaria de Los Angeles Pineda, Sarah Frances Thompson, Kelly Summers, et al.
Respiratory Medicine|October 18, 2016
RISE-SSc: Riociguat in diffuse cutaneous systemic sclerosisOliver Distler, Janet Pope, Chris Denton, et al.
Arthritis and Rheumatism|July 20, 2011
Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single centerJanet Pope, Donna McBain, Lisa Petrlich, et al.
Arthritis Care & Research|September 1, 2010
Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspectiveJessica Widdifield, Sasha Bernatsky, J Michael Paterson, et al.
Rheumatology (Oxford, England)|August 15, 2019
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 yearsJanet Pope, Louis Bessette, Niall Jones, et al.
Arthritis Care & Research|July 27, 2012
Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritisJessica Widdifield, Sasha Bernatsky, J Michael Paterson, et al.
Arthritis and Rheumatism|January 1, 2009
The cost of systemic sclerosisSasha Bernatsky, Marie Hudson, Pantelis Panopalis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 4, 2024
Characterization of Incident Interstitial Lung Disease in Late Systemic SclerosisSabrina Hoa, Claudie Berger, Nouha Lahmek, et al.
Open Access Rheumatology : Research and Reviews|June 17, 2024
Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment RetentionJanet Pope, Axel Finckh, Lucia Silva-Fernández, et al.
Pageof 17